Voyageur Pharmaceuticals (VM) Stock Chart & Stock Price History → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free VM Stock Alerts C$0.05 -0.01 (-9.09%) (As of 05:18 PM ET) Add Compare Share Share ChartStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Voyageur Pharmaceuticals Stock Price Performance5 Day Performance-9.09%1 Month Performance-23.08%3 Month Performance-33.33%6 Month Performance0.00%Year-To-Date Performance-33.33%1 Year Performance-37.50% Receive VM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Voyageur Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> VM Stock Chart for Thursday, April, 25, 2024 VM Chart by TradingView Voyageur Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/25/2024C$0.06C$0.05-9.09%C$0.05C$0.0510,000 shsC$6.94 million04/24/2024C$0.06C$0.06C$0.06C$0.045,225 shsC$7.64 million04/23/2024C$0.06C$0.06C$0.06C$0.045,225 shsC$7.64 million04/22/2024C$0.06C$0.06C$0.06C$0.045,225 shsC$7.64 million04/19/2024C$0.06C$0.06-8.33%C$0.06C$0.0671,000 shsC$7.64 million04/18/2024C$0.06C$0.06+9.09%C$0.06C$0.0610,500 shsC$8.33 million Get the Latest News and Ratings for VM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Voyageur Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/17/2024C$0.05C$0.06+22.22%C$0.06C$0.0627,900 shsC$7.64 million04/16/2024C$0.07C$0.05-30.77%C$0.07C$0.05171,000 shsC$6.25 million04/15/2024C$0.07C$0.07C$0.07C$0.077,500 shsC$9.02 million04/12/2024C$0.07C$0.07C$0.07C$0.0713,000 shsC$9.02 million04/11/2024C$0.06C$0.07+8.33%C$0.07C$0.0713,000 shsC$9.67 million04/10/2024C$0.07C$0.06-14.29%C$0.07C$0.0633,136 shsC$8.93 million04/09/2024C$0.07C$0.07C$0.07C$0.0735,500 shsC$10.42 million04/08/2024C$0.07C$0.07+7.69%C$0.07C$0.0735,500 shsC$10.42 million04/05/2024C$0.07C$0.07C$0.07C$0.0717,000 shsC$9.67 million04/04/2024C$0.06C$0.07+8.33%C$0.07C$0.0710,119 shsC$9.67 million04/03/2024C$0.06C$0.06C$0.07C$0.0679,900 shsC$8.93 million04/02/2024C$0.07C$0.06-7.69%C$0.07C$0.0679,900 shsC$8.93 million04/01/2024C$0.07C$0.07-7.14%C$0.07C$0.0667,000 shsC$9.67 million03/29/2024C$0.07C$0.07C$0.07C$0.0725,100 shsC$10.42 million03/28/2024C$0.07C$0.07C$0.07C$0.0725,100 shsC$10.42 million03/27/2024C$0.07C$0.07C$0.07C$0.0725,100 shsC$10.42 million03/26/2024C$0.07C$0.07+7.69%C$0.07C$0.0725,100 shsC$10.42 million03/25/2024C$0.07C$0.07C$0.07C$0.0717,000 shsC$9.67 million03/22/2024C$0.07C$0.07-7.14%C$0.07C$0.0793,300 shsC$9.67 million03/21/2024C$0.07C$0.07C$0.07C$0.072,000 shsC$10.42 million03/20/2024C$0.07C$0.07C$0.07C$0.072,000 shsC$10.42 million03/19/2024C$0.07C$0.07C$0.07C$0.0720,312 shsC$10.42 million03/18/2024C$0.07C$0.07C$0.07C$0.0766,000 shsC$10.42 million03/15/2024C$0.08C$0.07-6.67%C$0.07C$0.072,000 shsC$10.42 million03/14/2024C$0.08C$0.08C$0.08C$0.082,000 shsC$11.16 million03/13/2024C$0.07C$0.08+7.14%C$0.08C$0.082,000 shsC$11.16 million03/12/2024C$0.07C$0.07C$0.08C$0.074,186 shsC$10.42 million03/11/2024C$0.07C$0.07C$0.07C$0.0717,000 shsC$10.42 million03/08/2024C$0.08C$0.07-6.67%C$0.07C$0.07113,000 shsC$9.99 million03/07/2024C$0.08C$0.08-6.25%C$0.08C$0.0811,000 shsC$10.70 million03/06/2024C$0.09C$0.08-5.88%C$0.08C$0.082,000 shsC$11.42 million03/05/2024C$0.08C$0.09+6.25%C$0.09C$0.093,000 shsC$12.13 million03/04/2024C$0.08C$0.08+6.67%C$0.09C$0.08138,187 shsC$11.42 million03/01/2024C$0.07C$0.08+7.14%C$0.09C$0.0899,000 shsC$10.70 millionBetter than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>>02/29/2024C$0.07C$0.07C$0.08C$0.0765,800 shsC$9.99 million02/28/2024C$0.07C$0.07C$0.08C$0.0765,800 shsC$9.99 million02/27/2024C$0.07C$0.07C$0.08C$0.0765,800 shsC$9.99 million02/26/2024C$0.08C$0.07-6.67%C$0.08C$0.0765,800 shsC$9.99 million02/23/2024C$0.08C$0.08C$0.08C$0.0772,550 shsC$10.70 million02/22/2024C$0.07C$0.08+7.14%C$0.08C$0.0877,531 shsC$10.70 million02/21/2024C$0.07C$0.07C$0.08C$0.0730,000 shsC$9.99 million02/20/2024C$0.07C$0.07C$0.08C$0.0730,000 shsC$9.99 million02/19/2024C$0.07C$0.07C$0.08C$0.0730,000 shsC$9.99 million02/16/2024C$0.07C$0.07C$0.08C$0.0730,000 shsC$9.99 million02/15/2024C$0.07C$0.07C$0.08C$0.0765,000 shsC$9.99 million02/14/2024C$0.08C$0.07-12.50%C$0.08C$0.0765,000 shsC$9.99 million02/13/2024C$0.08C$0.08C$0.08C$0.0834,850 shsC$11.42 million02/12/2024C$0.08C$0.08+6.67%C$0.08C$0.0834,850 shsC$11.42 million02/09/2024C$0.08C$0.08-6.25%C$0.08C$0.081,800 shsC$10.70 million02/08/2024C$0.09C$0.08-5.88%C$0.09C$0.08447,000 shsC$11.42 million02/07/2024C$0.09C$0.09-5.56%C$0.09C$0.08192,000 shsC$12.13 million02/06/2024C$0.08C$0.09+12.50%C$0.09C$0.0925,000 shsC$12.84 million02/05/2024C$0.08C$0.08C$0.09C$0.08199,008 shsC$11.42 million02/02/2024C$0.08C$0.08+6.67%C$0.09C$0.08199,010 shsC$11.42 million02/01/2024C$0.08C$0.08-6.25%C$0.09C$0.07119,500 shsC$10.70 million01/31/2024C$0.08C$0.08C$0.09C$0.08182,000 shsC$11.42 million01/30/2024C$0.08C$0.08+6.67%C$0.09C$0.08261,250 shsC$11.42 million01/29/2024C$0.08C$0.08C$0.08C$0.0857,000 shsC$10.70 million01/26/2024C$0.08C$0.08C$0.08C$0.0857,000 shsC$9.95 million01/25/2024C$0.08C$0.08-6.25%C$0.08C$0.0852,000 shsC$9.95 million01/24/2024C$0.08C$0.08+6.67%C$0.08C$0.081,000 shsC$10.62 million Related Companies: Crescita Therapeutics Stock Chart Medicure Stock Chart Valeo Pharma Stock Chart Delta 9 Cannabis Stock Chart Willow Biosciences Stock Chart Entourage Health Stock Chart Aequus Pharmaceuticals Stock Chart Indiva Stock Chart MediPharm Labs Stock Chart Titan Medical Stock Chart Receive VM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Voyageur Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (CVE:VM) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Voyageur Pharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
